REVOLUTION, Invivyd’s development program for VYD2311, comprises the DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID ...
At this time, I would like to welcome everyone to the QuickLogic Corporation's Third Quarter Fiscal 2025 Earnings Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback